Literature DB >> 18054461

Acute deviations from long-term trait depressive symptoms predict systemic inflammatory activity.

Nicolas Rohleder1, Gregory E Miller.   

Abstract

OBJECTIVE: Depressive symptoms increase morbidity and mortality from coronary heart disease and systemic inflammation has been proposed as the underlying mechanism. While higher levels of inflammatory mediators have been found in dysphoric individuals, it is not known whether long-term or short-term mood changes are responsible for this phenomenon.
METHODS: A sample of 65 young women provided weekly web-based self-ratings of depressive mood over a period of 20 weeks using the CES-D, and systemic inflammation was assessed by measuring plasma interleukin-6 (IL-6) and C-reactive protein (CRP) before and after the observation period. CES-D ratings were used to develop state and trait indicators of depressed mood and evaluate their relationship with inflammatory mediators.
RESULTS: Hierarchical linear regressions controlling for baseline inflammation, age, and BMI revealed that trait levels of depressive symptoms were not associated with IL-6 (beta=0.09; n.s.) and CRP (beta=0.01; n.s.) concentrations after the observation period. In contrast, state levels of depressive symptoms were associated with changes in IL-6, but not CRP, particularly when they were indexed as the disparity between a person's trait level of symptoms and her CES-D score just prior to IL-6 assessment (beta=0.35; p=0.03).
CONCLUSION: These results lead us to conclude that in young women, state, rather than trait depressed mood stimulates peripheral inflammation as measured by IL-6. This pattern suggests that in this age group, fast-reacting inflammatory mediators such as IL-6 probably respond to short-term changes, for example, in stress hormones or stress hormone sensitivity, rather than long-term dysregulations of allostatic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054461     DOI: 10.1016/j.bbi.2007.10.012

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  8 in total

1.  Personality and disease.

Authors:  John P Capitanio
Journal:  Brain Behav Immun       Date:  2008-03-28       Impact factor: 7.217

Review 2.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

3.  Situational versus dispositional measurement of catastrophizing: associations with pain responses in multiple samples.

Authors:  Claudia M Campbell; Tarek Kronfli; Luis F Buenaver; Michael T Smith; Chantal Berna; Jennifer A Haythornthwaite; Robert R Edwards
Journal:  J Pain       Date:  2010-05       Impact factor: 5.820

Review 4.  Immune suppression and immune activation in depression.

Authors:  Joshua Blume; Steven D Douglas; Dwight L Evans
Journal:  Brain Behav Immun       Date:  2010-10-16       Impact factor: 7.217

5.  Inflammation and depression in young people: a systematic review and proposed inflammatory pathways.

Authors:  Yara J Toenders; Liliana Laskaris; Christopher G Davey; Michael Berk; Yuri Milaneschi; Femke Lamers; Brenda W J H Penninx; Lianne Schmaal
Journal:  Mol Psychiatry       Date:  2021-10-11       Impact factor: 15.992

6.  Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality.

Authors:  Aric A Prather; Mordechai Rabinovitz; Bruce G Pollock; Francis E Lotrich
Journal:  Brain Behav Immun       Date:  2009-07-15       Impact factor: 7.217

7.  Pilot Study of Parent Psychophysiologic Outcomes in Pediatric Hematopoietic Stem Cell Transplantation.

Authors:  Jessica Ward; Barbara Swanson; Louis Fogg; Cheryl Rodgers
Journal:  Cancer Nurs       Date:  2017 May/Jun       Impact factor: 2.592

8.  Cytokine alterations in pediatric internalizing disorders: Systematic review and exploratory multi-variate meta-analysis.

Authors:  Aaron S Howe; David A Lynch
Journal:  Brain Behav Immun Health       Date:  2022-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.